EP3534917
ENHANCEMENT OF MSC IMMUNOMODULATORY PROPERTIES BY TREPROSTINIL
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.10.2017EP published:
24.8.2022EP application number:
17808627.8
EPO information:
European Patent Register
Max expiry date:
22.10.2037
Title in English:
ENHANCEMENT OF MSC IMMUNOMODULATORY PROPERTIES BY TREPROSTINILLanguage of the patent:
English
Timeline
Today
23.10.2017EP application
24.8.2022EP Publication
Owner
Name:
United Therapeutics CorporationAddress:
1040 Spring Street, Silver Spring, MD 20910, US
Inventor
Name:
ILAGAN, Roger MarquezAddress:
Durham North Carolina 27705, US
Name:
HOGAN, SarahAddress:
Raleigh North Carolina 27613, US
Name:
CHEADLE, John B.Address:
Durham North Carolina 27705, US
Priority
Number:
201662411950 PDate:
24.10.2016Country:
US
Classification
Categories:
A61K 35/28, C12N 5/0789, A61P 9/00, A61P 9/10, A61P 11/00